These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
776 related articles for article (PubMed ID: 26754860)
1. Results of a comparative analysis of magnetic resonance imaging-targeted versus three-dimensional transrectal ultrasound prostate biopsies: Size does matter. Peltier A; Aoun F; Albisinni S; Marcelis Q; Ledinh D; Paesmans M; Lemort M; van Velthoven R Scand J Urol; 2016 Jun; 50(3):144-8. PubMed ID: 26754860 [TBL] [Abstract][Full Text] [Related]
2. Impact of Relative Volume Difference Between Magnetic Resonance Imaging and Three-dimensional Transrectal Ultrasound Segmentation on Clinically Significant Prostate Cancer Detection in Fusion Magnetic Resonance Imaging-targeted Biopsy. Lenfant L; Beitone C; Troccaz J; Beaugerie A; Rouprêt M; Seisen T; Renard-Penna R; Voros S; Mozer PC Eur Urol Oncol; 2024 Jun; 7(3):430-437. PubMed ID: 37599199 [TBL] [Abstract][Full Text] [Related]
3. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676 [TBL] [Abstract][Full Text] [Related]
4. Accuracy of Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies to Diagnose Clinically Significant Prostate Cancer in Enlarged Compared to Smaller Prostates. de Gorski A; Rouprêt M; Peyronnet B; Le Cossec C; Granger B; Comperat E; Cussenot O; Renard-Penna R; Mozer P J Urol; 2015 Sep; 194(3):669-73. PubMed ID: 25784374 [TBL] [Abstract][Full Text] [Related]
5. MRI-guided biopsy of the prostate: correlation between the cancer detection rate and the number of previous negative TRUS biopsies. Durmuş T; Reichelt U; Huppertz A; Hamm B; Beyersdorff D; Franiel T Diagn Interv Radiol; 2013; 19(5):411-7. PubMed ID: 23886937 [TBL] [Abstract][Full Text] [Related]
6. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy. Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233 [TBL] [Abstract][Full Text] [Related]
7. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care? Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824 [TBL] [Abstract][Full Text] [Related]
8. MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men. Yarlagadda VK; Lai WS; Gordetsky JB; Porter KK; Nix JW; Thomas JV; Rais-Bahrami S Diagn Interv Radiol; 2018; 24(3):115-120. PubMed ID: 29770762 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis. Martin PR; Cool DW; Romagnoli C; Fenster A; Ward AD Med Phys; 2014 Jul; 41(7):073504. PubMed ID: 24989418 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis. Choi YH; Kang MY; Sung HH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Kim CK; Park BK; Lee HM Clin Genitourin Cancer; 2019 Feb; 17(1):e19-e25. PubMed ID: 30415878 [TBL] [Abstract][Full Text] [Related]
11. A Prospective Comparison of Selective Multiparametric Magnetic Resonance Imaging Fusion-Targeted and Systematic Transrectal Ultrasound-Guided Biopsies for Detecting Prostate Cancer in Men Undergoing Repeated Biopsies. Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS Urol Int; 2017; 99(4):384-391. PubMed ID: 28651247 [TBL] [Abstract][Full Text] [Related]
12. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer. Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210 [TBL] [Abstract][Full Text] [Related]
13. Transrectal Ultrasound-Guided Prostate Biopsy for Cancer Detection: Performance of 2D-, 3D- and 3D-MRI Fusion Targeted Techniques. Klein J; de Górski A; Benamran D; Vallee JP; De Perrot T; Wirth GJ; Iselin CE Urol Int; 2017; 98(1):7-14. PubMed ID: 27784024 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Schoots IG; Roobol MJ; Nieboer D; Bangma CH; Steyerberg EW; Hunink MG Eur Urol; 2015 Sep; 68(3):438-50. PubMed ID: 25480312 [TBL] [Abstract][Full Text] [Related]
15. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer. Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235 [TBL] [Abstract][Full Text] [Related]
16. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial. Tonttila PP; Lantto J; Pääkkö E; Piippo U; Kauppila S; Lammentausta E; Ohtonen P; Vaarala MH Eur Urol; 2016 Mar; 69(3):419-25. PubMed ID: 26033153 [TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973 [TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance. Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939 [TBL] [Abstract][Full Text] [Related]
19. Multiparametric MRI in detection and staging of prostate cancer. Boesen L Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066 [TBL] [Abstract][Full Text] [Related]
20. Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies. Arsov C; Rabenalt R; Blondin D; Quentin M; Hiester A; Godehardt E; Gabbert HE; Becker N; Antoch G; Albers P; Schimmöller L Eur Urol; 2015 Oct; 68(4):713-20. PubMed ID: 26116294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]